Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries. RMD open. 2018;4(2):e000809.

28/02/2022

Lauper K, Mongin D, Iannone F, Klami Kristianslund E, Kvien TK, Nordström D, et al.

Epub 2018/11/30. doi: 10.1136/rmdopen-2018-000809. PubMed PMID: 30488002; PubMed Central PMCID: PMCPMC6241977.